Patent details

EP1229047 Title: IL-1 Receptor fusion proteins used as antagonists and methods of making and using

Basic Information

Publication number:
EP1229047
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP020078317
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
IL-1 Receptor fusion proteins used as antagonists and methods of making and using
French Title of Invention:
Protéines de fusion du récepteur de IL-1 utilisées comme antagonistes et méthodes d'utilisation et de fabrication
German Title of Invention:
IL-1 Rezeptor Fusionsproteine verwendet als Antagoniste und Verfahren zu deren Verwendung und Herstellung
SPC Number:

Dates

Filing date:
22/09/1999
Grant date:
24/11/2004
EP Publication Date:
24/11/2004
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/08/2002
EP B1 Publication Date:
24/11/2004
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
22/09/2005
Expiration date:
22/09/2019
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
22/09/1999
 
 

Name:
REGENERON PHARMACEUTICALS INC.
Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591-6707, United States (US)

Inventor

1

Name:
Stahl Neil
Address:
United States (US)

2

Name:
Yancopoulos George D.
Address:
United States (US)

Priority

1

Priority Number:
101858 P
Priority Date:
25/09/1998
Priority Country:
United States (US)

2

Priority Number:
313942
Priority Date:
19/05/1999
Priority Country:
United States (US)

Classification

Main IPC Class:
C12N 15/62;
Filing date Document type Number of pages